Mogens Schou and the use of lithium in psychiatry [3];Mogens Schou e o uso do lítio em psiquiatria

Revista Brasileira de Psiquiatria

Volumn 28, Issue 1, 2006, Pages 82-83

  Gazalle, Fernando Kratz ^a   Kapczinski, Flávio ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM;

AUSTRALIA; BIPOLAR DISORDER; DRUG INDUSTRY; DRUG USE; EUROPE; HUMAN; LETTER; MANIA; PSYCHIATRY; PSYCHOPHARMACOLOGY; SCIENTIFIC LITERATURE; UNITED STATES;

EID: 33645455472     PISSN: 15164446     EISSN: 15164446     Source Type: Journal    
DOI: 10.1590/S1516-44462006000100018     Document Type: Letter

References (5)

1. Fieve RR. Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise. Bipolar Disord. 1999;1(2):67-70.
2. Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17(4):250-60.
3. Schlagenhauf G, Tupin J, White RB. The use of lithium carbonate in the treatment of manic psychoses. Am J Psychiatry. 1966;123(2):199-207.
4. Prien RF, Caffey EM Jr, Klett CJ. A comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry. 1972;26(2):146-53.
5. Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindram A, Schaffer A, Connolly M, Gorman CP. Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(Suppl 3):5-69.